enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Hope for Parkinson’s disease symptoms is found in ... - AOL

   www.aol.com/finance/hope-parkinson-disease...

   Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. ... [medication targeting specific dopamine receptors] for the treatment of Parkinson's ...

3. Dopamine agonist - Wikipedia

   en.wikipedia.org/wiki/Dopamine_agonist

   Dopamine agonists are mainly used to treat Parkinson's disease, but also hyperprolactinemia and restless legs syndrome. [15] The side effects are predominantly collected from studies of Parkinson's disease, where dopamine agonists are commonly used as a first-line treatment with levodopa. [16]

4. AbbVie's Early Parkinson's Candidate Hits Primary Goal In ...

   www.aol.com/abbvies-early-parkinsons-candidate...

   Tavapadon is the first and only D1/D5 partial agonist under investigation as a once-daily treatment for Parkinson's disease. The TEMPO-2 trial evaluated the efficacy, safety and tolerability of a ...

5. Bromocriptine - Wikipedia

   en.wikipedia.org/wiki/Bromocriptine

   Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, [1] is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.

6. Tavapadon - Wikipedia

   en.wikipedia.org/wiki/Tavapadon

   Tavapadon (developmental code names CVL-751, PF-06649751) is a dopamine receptor agonist which is under development for the treatment of Parkinson's disease. [2] [3] [4] It is under development by Cerevel Therapeutics, which acquired tavapadon from Pfizer in 2018. [2]

7. Ropinirole - Wikipedia

   en.wikipedia.org/wiki/Ropinirole

   It is a dopamine agonist and works by triggering dopamine D 2 receptors. [4] It was approved for medical use in the United States in 1997. [4] It is available as a generic medication. [3] In 2022, it was the 163rd most commonly prescribed medication in the United States, with more than 3 million prescriptions. [6] [7]